N@N

Vikram Purohit Maintained (AXSM) at Hold with Decreased Target to $83 on, Apr 12th, 2023

^{Published on 2024-10-28 02:43:02 - WOPRAI, Vikram Purohit}
 

Vikram Purohit of Morgan Stanley, Maintained "Axsome Therapeutics, Inc." (AXSM) at Hold with Decreased Target from $85 to $83 on, Apr 12th, 2023.

Vikram has made no other calls on AXSM in the last 4 months.

There are 6 other peers that have a rating on AXSM. Out of the 6 peers that are also analyzing AXSM, 1 agrees with Vikram's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• David Amsellem of "Piper Sandler" Initiated at Hold and Held Target at $75 on, Thursday, January 5th, 2023

These are the ratings of the 5 analyists that currently disagree with Vikram

---

• Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $200 on, Monday, March 20th, 2023
• Graig Suvannavejh of "Mizuho" Reiterated at Strong Buy and Held Target at $84 on, Monday, March 13th, 2023
• Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Decreased Target to $90 on, Tuesday, February 28th, 2023
• Jason Gerberry of "B of A Securities" Reiterated at Sell and Held Target at $52 on, Tuesday, February 14th, 2023
• Robert Hazlett of "BTIG" Maintained at Strong Buy with Increased Target to $98 on, Friday, December 23rd, 2022

Contributing Sources

---